Subgroup analysis of male patients with stage II or III NPC by Zhang et al. [13] revealed a high VCA-IgA level was associated with a better prognosis than low VCA-IgA level in patients with blood group A. Moreover, pre-treatment EBV DNA has been proven to correlate with tumor stage in NPC [23–25]. This evidence concerns the gene CD79A and neoplasm.